Conviction
$ Value
$214K
Shares
36,506
Price
$6
Filed
Aug 14
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 50% (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
WILSON TROY EDWARD
Title
President and CEO
CIK
0001589597
Roles
Transaction Details
Transaction Date
2025-08-12
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
37,474
Footnotes
This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan. | This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Filing Info
WILSON TROY EDWARD's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-23 | KURA | M | $38K |
| 2026-03-23 | KURA | M | $0 |
| 2026-01-02 | KURA | A | $0 |
| 2025-11-13 | KURA | A | $0 |
| 2025-09-29 | KURA | ▼ | $327K |
| 2025-09-27 | KURA | A | $0 |
| 2025-09-08 | KURA | ▲ | $410K ★ |
| 2025-09-05 | RNA | M | $181K |
| 2025-09-05 | RNA | ▼ | $725K |
| 2025-09-05 | RNA | ▼ | $750K |
Other Insiders at KURA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILSON TROY EDWARD
President and CEO
|
— | — | 2026-03-23 |
|
FORD KATHLEEN
Chief Operating Officer
|
— | $15K | 2026-01-27 |
|
Bair Teresa Brophy
Chief Legal Officer
|
— | $95K | 2026-01-27 |
|
DOYLE THOMAS JAMES
SVP, Finance & Accounting
|
— | $60K | 2026-01-27 |
|
Powl Brian T.
Chief Commercial Officer
|
— | $54K | 2026-01-27 |
|
Leoni Mollie
Chief Medical Officer
|
— | $69K | 2026-01-27 |
|
Burrows Francis
Chief Scientific Officer
|
— | $11K | 2026-01-27 |